Electronic Cigarettes (E-cigarettes) as a Harm Reduction Strategy
| Status: | Completed |
|---|---|
| Conditions: | Smoking Cessation, Smoking Cessation, Tobacco Consumers |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 21 - 35 |
| Updated: | 3/24/2019 |
| Start Date: | May 2015 |
| End Date: | March 26, 2018 |
Assessing the Use of Electronic Cigarettes (E-cigarettes) as a Harm Reduction Strategy
The purpose of this study is to examine the feasibility of using e-cigarettes as a method for
harm reduction and the effects of providing e-cigarettes (or placebo e-cigarettes) on smoking
outcomes. Participants will be randomized to receive either e-cigarettes with nicotine
cartridges or e-cigarettes with placebo cartridges, and followed for 3 weeks.
harm reduction and the effects of providing e-cigarettes (or placebo e-cigarettes) on smoking
outcomes. Participants will be randomized to receive either e-cigarettes with nicotine
cartridges or e-cigarettes with placebo cartridges, and followed for 3 weeks.
This pilot study will be a two-arm, randomized controlled trial. The investigator will
randomize 40 participants into each intervention arm. Participants will be randomized to one
of the two arms: e-cigarettes with nicotine cartridges or e-cigarettes with placebo
cartridges (0mg). Participants and research assistants will be blind to the allocation of
nicotine or placebo e-cigarettes as there are no difference in appearance or odor of the mist
emitted from the e-cigarettes with and without nicotine containing cartridges. Participants
will be asked to track their nicotine use via text message. All participants will receive a
20-30 minute behavioral counseling consultation with a trained tobacco counselor. Counselors
will review each participant's smoking pattern and offer tailored behavioral and
environmental change strategies including specific smoking reduction strategy options.
Participants will be given a supply of e-cigarettes and followed for 3 weeks
randomize 40 participants into each intervention arm. Participants will be randomized to one
of the two arms: e-cigarettes with nicotine cartridges or e-cigarettes with placebo
cartridges (0mg). Participants and research assistants will be blind to the allocation of
nicotine or placebo e-cigarettes as there are no difference in appearance or odor of the mist
emitted from the e-cigarettes with and without nicotine containing cartridges. Participants
will be asked to track their nicotine use via text message. All participants will receive a
20-30 minute behavioral counseling consultation with a trained tobacco counselor. Counselors
will review each participant's smoking pattern and offer tailored behavioral and
environmental change strategies including specific smoking reduction strategy options.
Participants will be given a supply of e-cigarettes and followed for 3 weeks
Inclusion Criteria:
- 21-35 years old
- daily smokers who smoke at least 10 cigarettes per day (CPD)
- interested in reducing CPDs
- able to provide consent
- Use a cell phone and are willing/able to receive and respond to daily text messages
regarding their cigarette use and e-cigarette use on their cell phone
- Willing to use an e-cigarette for 3 weeks
Exclusion Criteria:
- pregnant and/or breast feeding
- currently using smoking cessation medications (including other forms of Nicotine
Replacement Therapy (NRT), buproprion, or varenicline)
- enrolled in a smoking cessation program or another cessation trial
- have used an e-cigarette in the past 14 days
- have used any other tobacco products (pipe, cigar, cigarillos, snuff, chewing tobacco,
rolling tobacco, or hookah/shisha) in the past 30 days
- score ≥7 (men) or ≥5 (women) on the Alcohol Use Disorders Identification Test
(AUDIT-C),
- score ≥ 5 on the Drug Abuse Screening Test-10 (DAST)
- report having a history of asthma, other airways diseases, or heart disease.
We found this trial at
1
site
New York University School of Medicine NYU School of Medicine has a proud history that...
Click here to add this to my saved trials
